组织修复产品

Search documents
威高骨科收盘上涨1.52%,滚动市盈率52.03倍,总市值125.20亿元
Sou Hu Cai Jing· 2025-08-15 12:28
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Weigao Orthopedics in the medical device industry, noting its current stock price and market capitalization [1][2] - As of August 15, Weigao Orthopedics closed at 31.3 yuan, with a PE ratio of 52.03 and a total market value of 12.52 billion yuan [1] - The average PE ratio for the medical device industry is 56.58, with a median of 39.97, positioning Weigao Orthopedics at the 86th rank within the industry [1][2] Group 2 - The company reported a revenue of 290 million yuan for Q1 2025, reflecting a year-on-year decrease of 16.59%, while net profit was 51.79 million yuan, showing a year-on-year increase of 48.37% [1] - The gross profit margin for Weigao Orthopedics stands at 63.68% [1] - The company holds a total of 371 patents, including 86 invention patents and 266 utility model patents, indicating a strong focus on innovation in orthopedic medical devices [1]
威高骨科收盘上涨1.35%,滚动市盈率53.54倍,总市值128.84亿元
Sou Hu Cai Jing· 2025-08-12 10:58
8月12日,威高骨科今日收盘32.21元,上涨1.35%,滚动市盈率PE(当前股价与前四季度每股收益总和 的比值)达到53.54倍,创353天以来新低,总市值128.84亿元。 最新一期业绩显示,2025年一季报,公司实现营业收入2.90亿元,同比-16.59%;净利润5178.90万元, 同比48.37%,销售毛利率63.68%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13威高骨科53.5457.583.22128.84亿行业平均 57.5153.344.97120.28亿行业中值41.2539.962.9558.75亿1九安医疗11.2611.380.89189.95亿2英科医疗 15.0516.231.34237.81亿3山东药玻16.1716.221.86152.96亿4新华医疗16.9415.701.38108.60亿5振德医疗 17.3716.371.1063.04亿6奥美医疗17.5417.191.8063.39亿7九强生物17.9216.672.2088.77亿8康德莱 18.7518.761.5540.40亿9维力医疗18.7920.082.3644.05亿10奥泰生物19. ...
威高骨科收盘上涨1.66%,滚动市盈率52.83倍,总市值127.12亿元
Sou Hu Cai Jing· 2025-08-11 11:57
Core Viewpoint - Weigao Orthopedics has a closing price of 31.78 yuan, with a PE ratio of 52.83, marking a new low in 208 days, and a total market capitalization of 12.712 billion yuan [1] Group 1: Company Overview - Weigao Orthopedics specializes in a wide range of orthopedic products, including spinal, trauma, joint, sports medicine, bone repair materials, tissue repair, and surgical instruments, making it a leading domestic enterprise in the orthopedic field [1] - The company holds a total of 371 patents, including 86 invention patents and 266 utility model patents [1] Group 2: Financial Performance - In the first quarter of 2025, Weigao Orthopedics reported an operating income of 290 million yuan, a year-on-year decrease of 16.59%, while net profit reached 51.789 million yuan, an increase of 48.37%, with a gross profit margin of 63.68% [1] Group 3: Shareholder Information - As of March 31, 2025, Weigao Orthopedics had 8,904 shareholders, a decrease of 302 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 4: Industry Comparison - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Weigao Orthopedics at the 86th position in the industry ranking [1][2]